These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19435921)

  • 1. Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
    Volchenboum SL; Li C; Li S; Attiyeh EF; Reynolds CP; Maris JM; Look AT; George RE
    Cancer Res; 2009 May; 69(10):4143-9. PubMed ID: 19435921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
    Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
    Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
    Kryh H; Carén H; Erichsen J; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2011 Sep; 12():443. PubMed ID: 21899760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for chromosome 14q in neuroblastoma.
    Thompson PM; Seifried BA; Kyemba SK; Jensen SJ; Guo C; Maris JM; Brodeur GM; Stram DO; Seeger RC; Gerbing R; Matthay KK; Matise TC; White PS
    Med Pediatr Oncol; 2001 Jan; 36(1):28-31. PubMed ID: 11464899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform.
    Maris JM; Hii G; Gelfand CA; Varde S; White PS; Rappaport E; Surrey S; Fortina P
    Genome Res; 2005 Aug; 15(8):1168-76. PubMed ID: 16077016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.
    Cifola I; Bianchi C; Mangano E; Bombelli S; Frascati F; Fasoli E; Ferrero S; Di Stefano V; Zipeto MA; Magni F; Signorini S; Battaglia C; Perego RA
    BMC Cancer; 2011 Jun; 11():244. PubMed ID: 21668985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of loss of heterozygosity and copy number amplification in uterine leiomyomas using the 100K single nucleotide polymorphism array.
    Meadows KL; Andrews DM; Xu Z; Carswell GK; Laughlin SK; Baird DD; Taylor JA
    Exp Mol Pathol; 2011 Aug; 91(1):434-9. PubMed ID: 21497600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide analysis of loss of heterozygosity and chromosomal copy number variation in Proteus syndrome using high-density SNP microarrays.
    Yilmaz A; Hamel N; Schwartz CE; Houlston RS; Harper JI; Foulkes WD
    J Hum Genet; 2010 Sep; 55(9):627-30. PubMed ID: 20555334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.